A MacArthur 'genius' on pharma's patent games; an honest conversation on 340B

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: Q&A: A health justice lawyer and new MacArthur 'genius' on pharma's patent games By Ambar Castillo MacArthur Foundation “What we need to do now is ... understand: Why did [pharma] have this much power in the first place? And patents are the first place to look.” Read More When it comes to addiction, Americans' word choices are part of the problem By Lev Facher Hyacinth Empinado/STAT There's a push to swap out terms like "addict" or "substance abuse" in favor of language that recognizes addiction as a medical condition. Read More Opinion: After 30 years of 340B, it's time for data and an honest conversation By John Michael O'Brien Adobe Stock The 340B Drug Discount Program is now a giant federal program. But it's impossible to tell where the money is going. That needs to change. Read More Sponsored Insight by Optum Clinicogenomics: How new, linked data is advancing life sciences research Clinicogenomics offers life sciences researchers a powerful new tool by linking genomic data to rich, longitudinal clinical information. The life science research community is only beginning to unlock its potential to better understand disease pathways, discover novel therapeutic targets, identify variation in disease onset and progression, and evaluate drug safety and efficacy. Read this white paper to get an in-depth look into this rapidly evolving field of research. STAT+: Biotech's newest odd couple: A pharma insider and a music maven launch a health care VC By Allison DeAngelis Courtesy Stefan Simchowitz Tim Wright and D.A. Wallach have forged an unlikely alliance based on their shared interest in health care and investment. Read More Wednesday, October 26, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser